药品注册申请号:018896
申请类型:NDA (新药申请)
申请人:HOSPIRA
申请人全名:HOSPIRA INC
产品信息
产品号商品名活性成分剂型/给药途径规格/剂量参比药物(RLD)生物等效参考标准(RS)治疗等效代码该申请号批准日期该产品号批准日期市场状态
001 POTASSIUM ACETATE POTASSIUM ACETATE INJECTABLE;INJECTION 2MEQ/ML Yes Yes AP 1984/07/20 1984/07/20 Prescription
批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期提交号审批结论申请内容分类审评优先级;罕用药状态通知信、审评文件、说明书、包装标签备注
2014/06/12 SUPPL-22(补充) Approval Manufacturing (CMC) STANDARD
2002/12/24 SUPPL-12(补充) Approval Manufacturing (CMC) STANDARD
2001/02/16 SUPPL-11(补充) Approval Manufacturing (CMC) STANDARD
2000/02/11 SUPPL-8(补充) Approval Labeling STANDARD
1999/08/31 SUPPL-10(补充) Approval Manufacturing (CMC) STANDARD
1999/01/22 SUPPL-9(补充) Approval Manufacturing (CMC) STANDARD
1998/08/13 SUPPL-7(补充) Approval Labeling STANDARD
1997/01/17 SUPPL-5(补充) Approval Manufacturing (CMC) STANDARD
1996/08/29 SUPPL-6(补充) Approval Manufacturing (CMC) STANDARD
1988/10/21 SUPPL-3(补充) Approval Manufacturing (CMC) STANDARD
1987/12/11 SUPPL-2(补充) Approval Manufacturing (CMC) STANDARD
1986/07/24 SUPPL-1(补充) Approval Manufacturing (CMC) STANDARD
1984/07/20 ORIG-1(原始申请) Approval Type 5 - New Formulation or New Manufacturer STANDARD
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号专利号专利过期日是否物质专利是否产品专利专利用途代码撤销请求提交日期专利下载备注
与本品相关的市场独占权保护信息
关联产品号独占权代码失效日期备注
与本品治疗等效的药品
活性成分:POTASSIUM ACETATE 剂型/给药途径:INJECTABLE;INJECTION 规格:2MEQ/ML 治疗等效代码:AP
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
018896 001 NDA POTASSIUM ACETATE POTASSIUM ACETATE INJECTABLE;INJECTION 2MEQ/ML Prescription Yes Yes AP 1984/07/20 HOSPIRA
206203 001 ANDA POTASSIUM ACETATE POTASSIUM ACETATE INJECTABLE;INJECTION 2MEQ/ML Prescription No No AP 2015/12/29 EXELA PHARMA
212692 001 ANDA POTASSIUM ACETATE POTASSIUM ACETATE INJECTABLE;INJECTION 2MEQ/ML Prescription No No AP 2021/10/20 EXELA PHARMA
217515 001 ANDA POTASSIUM ACETATE POTASSIUM ACETATE INJECTABLE;INJECTION 2MEQ/ML Prescription No No AP 2024/11/27 FRESENIUS KABI USA
更多信息
药品NDC数据与药品包装、标签说明书
©2006-2024 DrugFuture->U.S. FDA Drugs Database